Evidence map›Paper›PMID 23159957›Full record

ArticleExperimental gerontology2013

Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age.

Gautam Sikka, Karen L Miller, Jochen Steppan, Deepesh Pandey, Sung M Jung, Charles D Fraser, Carla Ellis, Daniel Ross, Koenraad Vandegaer, Djahida Bedja and 4 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Experimental gerontology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03671746 (Inflammatory Response to Trauma - Does Early Cytokine Modulation Improve Patient Outcome), which is not on this map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03671746 phase1completednot on this mapstarted 2019, after this paper: background citation

Inflammatory Response to Trauma - Does Early Cytokine Modulation Improve Patient Outcome

TypeinterventionalSponsorArun AnejaRan2019 to 2023Enrolled70ConditionsPolytraumaArmsKetorolac, Saline Solution
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 100 citations in OpenAlex.

  1. CD163Basic research in cardiology · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Physiological Systems in Promoting Frailty.Comprehensive Physiology · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Maladaptive Changes Associated With Cardiac Aging Are Sex-Specific and Graded by Frailty and Inflammation in C57BL/6 Mice.The journals of gerontology. Series A, Biological sciences and medical sciences · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Gautam SikkaDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA. gsikka1@johnshopkins.edu
Karen L Miller
Jochen Steppan
Deepesh Pandey
Sung M Jung
Charles D Fraser
Carla Ellis
Daniel Ross
Koenraad Vandegaer
Djahida Bedja
Kathleen Gabrielson
Jeremy D Walston
Dan E Berkowitz
Lili A Barouch
Johns Hopkins University · USJohns Hopkins Medicine · USThe University of Texas Health Science Center at Houston · USYeungnam University · KR

Funding

Technological Assessment and Solutions Core - RC4P30AG021334 · NIA · JOHNS HOPKINS UNIVERSITY · PI Jeremy D Walston · 2003 to 2026
$33.2M
Transglutaminase 2 S-Nitrosylation: Role in Age-Related Vascular StiffnessR01HL105296 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BERKOWITZ, DAN E · 2010 to 2013
$1.6M
NHLBI NIH HHS HL105296-02NHLBI NIH HHS R01 HL105296NIA NIH HHS P30 AG021334
6 · The paper itself

Abstract

unlabelledCardiovascular dysfunction is a primary independent predictor of age-related morbidity and mortality. Frailty is associated with activation of inflammatory pathways and fatigue that commonly presents and progresses with age. Interleukin 10 (IL-10), the cytokine synthesis inhibitory factor, is an anti-inflammatory cytokine produced by immune and non-immune cells. Homozygous deletion of IL-10 in mice yields a phenotype that is consistent with human frailty, including age-related increases in serum inflammatory mediators, muscular weakness, higher levels of IGF-1 at midlife, and early mortality. While emerging evidence suggests a role for IL-10 in vascular protection, a clear mechanism has not yet been elucidated.

methodsIn order to evaluate the role of IL-10 in maintenance of vascular function, force tension myography was utilized to access ex-vivo endothelium dependent vasorelaxation in vessels isolated from IL-10 knockout IL-10(tm/tm) and control mice. Pulse wave velocity ((PWV), index of stiffness) of vasculature was measured using ultrasound and blood pressure was measured using the tail cuff method. Echocardiography was used to elucidated structure and functional changes in the heart.

resultsMean arterial pressures were significantly higher in IL-10(tm/tm) mice as compared to C57BL6/wild type (WT) controls. PWV was increased in IL-10(tm/tm) indicating stiffer vasculature. Endothelial intact aortic rings isolated from IL-10(tm/tm) mice demonstrated impaired vasodilation at low acetylcholine doses and vasoconstriction at higher doses whereas vasorelaxation responses were preserved in rings from WT mice. Cyclo-oxygenase (COX-2)/thromboxane A2 inhibitors improved endothelial dependent vasorelaxation and reversed vasoconstriction. Left ventricular end systolic diameter, left ventricular mass, isovolumic relaxation time, fractional shortening and ejection fraction were all significantly different in the aged IL-10(tm/tm) mice compared to WT mice.

conclusionAged IL-10(tm/tm) mice have stiffer vessels and decreased vascular relaxation due to an increase in eicosanoids, specifically COX-2 activity and resultant thromboxane A2 receptor activation. Our results also suggest that aging IL-10(tm/tm) mice have an increased heart size and impaired cardiac function compared to age-matched WT mice. While further studies will be necessary to determine if this age-related phenotype develops as a result of inflammatory pathway activation or lack of IL-10, it is essential for maintaining the vascular compliance and endothelial function during the aging process. Given that a similar cardiovascular phenotype is present in frail, older adults, these findings further support the utility of the IL-10(tm/tm) mouse as a model of frailty.

Indexed as

Age FactorsAgingAnimalsAortaArterial PressureCardiovascular DiseasesCyclooxygenase 2Cyclooxygenase 2 InhibitorsDose-Response Relationship, DrugEchocardiography, DopplerEndothelium, VascularGenotypeInflammationInflammation MediatorsInterleukin-10MiceCyclooxygenase 2Cyclooxygenase 2 InhibitorsIL10 protein, mouseInflammation MediatorsInterleukin-10Ptgs2 protein, mouseThromboxane A2Vasoconstrictor AgentsVasodilator Agents

Identifiers

PMID23159957
PMCPMC3744178
OpenAlexW2004024190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.